Dermapharm Holding SE (LON:0A5J)
London
· Delayed Price · Currency is GBP · Price in EUR 39.22
+0.30 (0.77%)
At close: Feb 21, 2025
Dermapharm Holding SE Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 1,752 | 1,978 | 1,792 | 4,038 | 2,748 | 1,813 | Upgrade
|
| Market Cap Growth | -14.28% | 10.40% | -55.63% | 46.97% | 51.52% | 65.17% | Upgrade
|
| Enterprise Value | 2,506 | 2,827 | 2,211 | 4,446 | 3,211 | 2,202 | Upgrade
|
| Last Close Price | 32.43 | 35.98 | 31.77 | 69.01 | 46.34 | - | Upgrade
|
| PE Ratio | 23.24 | 36.55 | 15.05 | 22.94 | 35.73 | 27.72 | Upgrade
|
| PS Ratio | 1.60 | 1.98 | 1.94 | 5.01 | 3.79 | 3.00 | Upgrade
|
| PB Ratio | 3.19 | 4.18 | 3.79 | 9.62 | 9.45 | 7.52 | Upgrade
|
| P/TBV Ratio | - | - | 41.95 | 310.95 | - | - | Upgrade
|
| P/FCF Ratio | 11.98 | 12.82 | 8.10 | 25.42 | 33.96 | 39.51 | Upgrade
|
| P/OCF Ratio | 9.56 | 10.39 | 7.00 | 19.20 | 23.39 | 21.27 | Upgrade
|
| EV/Sales Ratio | 2.58 | 2.83 | 2.40 | 5.51 | 4.43 | 3.64 | Upgrade
|
| EV/EBITDA Ratio | 12.52 | 14.79 | 8.25 | 16.95 | 23.11 | 19.86 | Upgrade
|
| EV/EBIT Ratio | 14.07 | 16.87 | 8.82 | 17.89 | 25.58 | 21.58 | Upgrade
|
| EV/FCF Ratio | 19.17 | 18.31 | 9.99 | 27.98 | 39.69 | 47.98 | Upgrade
|
| Debt / Equity Ratio | 1.74 | 1.98 | 0.97 | 1.16 | 1.87 | 1.95 | Upgrade
|
| Debt / EBITDA Ratio | 4.26 | 4.77 | 1.69 | 1.83 | 3.81 | 4.11 | Upgrade
|
| Debt / FCF Ratio | 6.53 | 6.07 | 2.07 | 3.07 | 6.72 | 10.24 | Upgrade
|
| Asset Turnover | 0.55 | 0.64 | 0.74 | 0.73 | 0.71 | 0.82 | Upgrade
|
| Inventory Turnover | 1.29 | 1.55 | 1.57 | 1.56 | 1.86 | 2.30 | Upgrade
|
| Quick Ratio | 0.65 | 0.75 | 1.18 | 1.61 | 1.39 | 1.68 | Upgrade
|
| Current Ratio | 1.66 | 1.60 | 2.45 | 3.34 | 3.01 | 3.45 | Upgrade
|
| Return on Equity (ROE) | 15.75% | 11.24% | 25.69% | 50.68% | 28.22% | 28.79% | Upgrade
|
| Return on Assets (ROA) | 6.26% | 6.76% | 12.53% | 14.06% | 7.72% | 8.61% | Upgrade
|
| Return on Capital (ROIC) | 8.23% | 9.03% | 16.60% | 18.39% | 9.89% | 10.76% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.26% | 10.94% | 23.66% | 23.65% | 12.84% | 12.78% | Upgrade
|
| Earnings Yield | 4.30% | 2.74% | 6.65% | 4.36% | 2.80% | 3.61% | Upgrade
|
| FCF Yield | 7.46% | 7.80% | 12.35% | 3.93% | 2.94% | 2.53% | Upgrade
|
| Dividend Yield | 1.90% | 2.12% | 2.93% | 2.64% | 1.70% | - | Upgrade
|
| Payout Ratio | 52.30% | 90.64% | 87.04% | 22.61% | 50.19% | 53.70% | Upgrade
|
| Buyback Yield / Dilution | -0.23% | - | - | - | - | -0.79% | Upgrade
|
| Total Shareholder Return | 1.71% | 2.12% | 2.93% | 2.64% | 1.70% | -0.79% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.